Peter Clapham
Impact in
- Cancer Research top 0.2%
- Cancer Genomics and Diagnostics
- Cancer-related molecular mechanisms research
- Molecular Biology top 0.5%
- RNA modifications and cancer
- Genomics and Phylogenetic Studies
- Epigenetics and DNA Methylation
- RNA Research and Splicing
- Bioinformatics and Genomic Networks
Papers in
-
- Cancer Genomics and Diagnostics 16
- Genetics 16
- Genetic Associations and Epidemiology 6
- Genomics and Rare Diseases 5
- Co-authors
- Munira A Kadhim (1 shared paper)Stephen R. Moore (1 shared paper)Denise A. Macdonald (1 shared paper)Guy M. P. Coates (1 shared paper)Guoying Qi (1 shared paper)Mark A. Hill (1 shared paper)John R. Ford (1 shared paper)K. M. S. Townsend (1 shared paper)
- Journals
- Nature Communications (16 papers)Nature (10 papers)Nucleic Acids Research (9 papers)Nature Genetics (5 papers)Radiation Research (1 paper)
- Partner nations
- United KingdomCanadaUnited States
In The Last Decade
Peter Clapham
50 papers receiving 18.9k citations
Peter Clapham's Hit Papers
Peers
Comparison fields: 5 of 179
- Cancer Research 5.3k
- Molecular Biology 10.2k
- Genetics 3.8k
- Oncology 2.2k
- Infectious Diseases 1.6k
Countries citing papers authored by Peter Clapham
This map shows the geographic impact of Peter Clapham's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Clapham with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Clapham more than expected).
Fields of papers citing papers by Peter Clapham
This network shows the impact of papers produced by Peter Clapham. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Clapham. The network helps show where Peter Clapham may publish in the future.
Co-authors
The 11 scholars most cited alongside Peter Clapham, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 50 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | The repertoire of mutational signatures in human cancer Hit paper breakdown → | 2020 | 2339 |
| 2 | Pan-cancer analysis of whole genomes Hit paper breakdown → | 2020 | 2109 |
| 3 | Ensembl 2016 Hit paper breakdown → | 2015 | 1085 |
| 4 | Ensembl 2014 Hit paper breakdown → | 2013 | 1058 |
| 5 | Ensembl 2015 Hit paper breakdown → | 2014 | 994 |
| 6 | Ensembl 2013 Hit paper breakdown → | 2012 | 761 |
| 7 | The UK10K project identifies rare variants in health and disease Hit paper breakdown → | 2015 | 760 |
| 8 | Ensembl 2012 Hit paper breakdown → | 2011 | 753 |
| 9 | The evolutionary history of 2,658 cancers Hit paper breakdown → | 2020 | 705 |
| 10 | SARS-CoV-2 evolution during treatment of chronic infection Hit paper breakdown → | 2021 | 698 |
| 11 | Ensembl 2009 Hit paper breakdown → | 2008 | 628 |
| 12 | Patterns of somatic structural variation in human cancer genomes Hit paper breakdown → | 2020 | 550 |
| 13 | 2010 | 538 | |
| 14 | Sensitivity of SARS-CoV-2 B.1.1.7 to mRNA vaccine-elicited antibodies Hit paper breakdown → | 2021 | 524 |
| 15 | Comprehensive analysis of chromothripsis in 2,658 human cancers using whole-genome sequencing Hit paper breakdown → | 2020 | 476 |
| 16 | Analyses of non-coding somatic drivers in 2,658 cancer whole genomes Hit paper breakdown → | 2020 | 419 |
| 17 | 2016 | 413 | |
| 18 | 2020 | 317 | |
| 19 | Recurrent emergence of SARS-CoV-2 spike deletion H69/V70 and its role in the Alpha variant B.1.1.7 Hit paper breakdown → | 2021 | 316 |
| 20 | Pan-cancer analysis of whole genomes identifies driver rearrangements promoted by LINE-1 retrotransposition Hit paper breakdown → | 2020 | 309 |
About Peter Clapham
Peter Clapham is a scholar working on Cancer Research, Genetics, Molecular Biology, Pathology and Forensic Medicine and Animal Science and Zoology, having authored 50 papers that have together received 19.0k indexed citations. Recurring topics across this work include Cancer Genomics and Diagnostics (16 papers), Genomics and Phylogenetic Studies (13 papers), Genetic factors in colorectal cancer (8 papers), Epigenetics and DNA Methylation (7 papers), Genomics and Chromatin Dynamics (6 papers), Genetic Associations and Epidemiology (6 papers), Genomics and Rare Diseases (5 papers) and Animal Virus Infections Studies (5 papers). The work is most often cited by research in Cancer Research (5.3k citations), Molecular Biology (10.2k citations), Genetics (3.8k citations), Oncology (2.2k citations) and Infectious Diseases (1.6k citations). Peter Clapham has collaborated with scholars based in United Kingdom, Canada and United States. Frequent co-authors include Munira A Kadhim, Stephen R. Moore, Denise A. Macdonald, Guy M. P. Coates, Guoying Qi, Mark A. Hill, John R. Ford, K. M. S. Townsend, David L. Stevens and DUDLEY T. GOODHEAD. Their work appears in journals such as Nature Communications, Nature, Nucleic Acids Research, Nature Genetics and Radiation Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.